Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Peter Diamandis Describes How Applying AI to Drug Discovery is Causing Positive Disruption to Biopharma

The content of Peter’s email blast has been edited by me (can’t help myself). But I believe I have captured its essence and hope you enjoy the retelling. As always your comments are welcomed.

What is Insilico Medicine?

Insilico Medicine is a pioneering drug company that is powered by a “drug discovery engine” that sifts through millions of data samples to determine the signature biological characteristics of specific diseases. It then identifies the most promising treatment targets and uses a new AI technique called generative adversarial networks (GANs) to create molecules perfectly suited against them.